Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

DNLIDNLI
Showing 8 of 31 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in DENALI THERAPEUTICS INC

BNP PARIBAS FINANCIAL MARKETS holds 25,071 shares of DNLI (DENALI THERAPEUTICS INC), worth $644,826 as of 2026-Q2. The position was decreased (-37.1% shares). DNLI represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.

Current Value

$644,826

Current Shares

25,071

Total Value Change

-$159,890

Total Shares Change

-2,554

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
25,071
-37.1%
$644,8260.0%$25.72
0
2026-Q1
Increased
39,893
+157.4%
$765,9460.0%$20.02
40
2025-Q4
Decreased
15,497
-94.1%
$255,8550.0%$16.41
0
2025-Q3
Increased
264,061
+1283.8%
$3.8M0.0%$14.52
43
2025-Q2
Increased
19,082
+119.0%
$266,9570.0%$14.10
37
2025-Q1
Decreased
8,715
-45.3%
$118,4800.0%$14.78
0
2024-Q4
Decreased
15,943
-42.3%
$324,9180.0%$20.24
0
2024-Q3
Increased
27,625
+230.2%
$804,7160.0%$29.43
40

Other major holders of DNLI: BAILLIE GIFFORD & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used